A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial with Withdrawal Design of AZD1419, a Toll-9 Agonist in Adults with Eosinophilic, Moderate to Severe Asthma

2019 ◽  
Author(s):  
I. Psallidas ◽  
V. Backer ◽  
P. Kuna ◽  
L. Molnar ◽  
M. Aurell ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Withdrawal Design

scholarly journals Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: a double‐blind placebo‐controlled trial

2021 ◽  
Author(s):  
Geertje M. de Boer ◽  
Gert‐Jan Braunstahl ◽  
Esmee K. van der Ploeg ◽  
Cathelijne M. van Zelst ◽  
Alie van Bruggen ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Controlled Trial ◽  
Bacterial Lysate ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

Thorax ◽  
2013 ◽  
Vol 68 (4) ◽  
pp. 322-329 ◽  
Author(s):  
Guy G Brusselle ◽  
Christine VanderStichele ◽  
Paul Jordens ◽  
René Deman ◽  
Hans Slabbynck ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

1997 ◽  
Vol 27 (8) ◽  
pp. 860-867 ◽  
Author(s):  
V.A. VARNEY ◽  
J. EDWARDS ◽  
K. TABBAH ◽  
H. BREWSTER ◽  
G. MAVROLEON ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Specific Immunotherapy ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic Hepatitis C

2001 ◽  
Vol 120 (5) ◽  
pp. A384-A384
Author(s):  
L MOLLISON ◽  
L TOTTEN ◽  
C HOVELL ◽  
K THAYNE ◽  
C CONNELLY ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Controlled Trial ◽  
Herbal Preparation ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Chinese Herbal
Sign in / Sign up

Export Citation Format

Share Document